Ovid Therapeutics (OVID) FCF Margin (2020 - 2025)
Ovid Therapeutics (OVID) posted FCF Margin of 1444.85% for Q4 2025, up 85.13% on a QoQ basis from 9716.67% in Q3 2025, and up 1168936.0% year-over-year from N/an in Q4 2024.
Ovid Therapeutics (OVID) FCF Margin (2020 - 2025) Analysis & Trends
Ovid Therapeutics' FCF Margin history runs 6 years deep, the most recent figure standing at 1444.85% for Q4 2025.
- Quarterly FCF Margin rose 1168936.0% year-over-year to 1444.85% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 588.58% (up 846634.0% YoY) and the FY2025 annual result came in at 528.13%, up 937399.0% from the prior year.
- FCF Margin was 1444.85% for Q4 2025 at Ovid Therapeutics, up from 9716.67% in the prior quarter.
- Across five years, FCF Margin topped out at 77.21% in Q1 2021 and bottomed at 114348.52% in Q3 2022.
- A 5-year average of 15508.63% and a median of 8951.04% in 2024 frame the typical range for FCF Margin.
- Peak annual rise in FCF Margin reached 10512100 bps in 2023, while the deepest fall reached 1698092 bps in 2023.
- Ovid Therapeutics' FCF Margin stood at 77.21% in 2021, then slumped by 26113 bps to 20085.72% in 2022, then jumped by 58 bps to 8437.32% in 2023, then plunged by 56 bps to 13134.21% in 2024, then jumped by 89 bps to 1444.85% in 2025.
- Business Quant data shows OVID's FCF Margin at 1444.85% in Q4 2025, 9716.67% in Q3 2025, and 76.85% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Ovid Therapeutics | 118.66 Mn | -36.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,444.85% |
| Sep 30, 2025 | -9,716.67% |
| Jun 30, 2025 | -76.85% |
| Mar 31, 2025 | -7,907.69% |
| Dec 31, 2024 | -13,134.21% |
| Sep 30, 2024 | -8,674.57% |
| Jun 30, 2024 | -8,492.31% |
| Mar 31, 2024 | -11,287.16% |
| Dec 31, 2023 | -8,437.32% |
| Sep 30, 2023 | -9,227.52% |
| Jun 30, 2023 | -15,617.33% |
| Mar 31, 2023 | -18,372.73% |
| Dec 31, 2022 | -20,085.72% |
| Sep 30, 2022 | -114,348.52% |
| Mar 31, 2022 | -1,391.80% |
| Mar 31, 2021 | 77.21% |
| Dec 31, 2020 | -257.53% |
| Sep 30, 2020 | -21.52% |